Cargando…
Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion
Several neurological disorders may benefit from gene therapy. However, even when using the lead vector candidate for intrathecal administration, adeno-associated virus serotype 9 (AAV9), the strength and distribution of gene transfer to the brain are inconsistent. On the basis of preliminary observa...
Autores principales: | Castle, Michael J., Cheng, Yuhsiang, Asokan, Aravind, Tuszynski, Mark H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235539/ https://www.ncbi.nlm.nih.gov/pubmed/30443600 http://dx.doi.org/10.1126/sciadv.aau9859 |
Ejemplares similares
-
CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
por: Murlidharan, Giridhar, et al.
Publicado: (2016) -
Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
por: Chatterjee, Diptaman, et al.
Publicado: (2021) -
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022) -
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021)